A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL

被引：18

作者：

SCHAID, DJ ^{[1
]}

INGLE, JN ^{[1
]}

WIEAND, S ^{[1
]}

AHMANN, DL ^{[1
]}

机构：

[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905

来源：

CONTROLLED CLINICAL TRIALS | 1988年 / 9卷 / 02期

关键词：

D O I：

10.1016/0197-2456(88)90032-3

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：107 / 118

页数：12

共 20 条

[1] AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P877
[2] AHMANN DL, 1972, CANC CHEMOTHER REP, V3, P29
[3] AHMANN DL, 1974, CANCER RES, V34, P27
[4] AHMANN DL, 1973, CANCER RES, V33, P1707
[5] AHMANN DL, 1974, CANCER CHEMOTH REP 1, V58, P861
[6] THE EFFECT ON SURVIVAL OF INITIAL CHEMOTHERAPY IN ADVANCED BREAST-CANCER - POLYCHEMOTHERAPY VERSUS SINGLE DRUG
AHMANN, DL
SCHAID, DJ
BISEL, HF
HAHN, RG
EDMONSON, JH
INGLE, JN
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) : 1928 - 1932
[7] CARTER SK, 1984, CANCER CLIN TRIALS M
[8] DESIGNS FOR GROUP SEQUENTIAL PHASE-II CLINICAL-TRIALS
CHANG, MN
THERNEAU, TM
WIEAND, HS
CHA, SS
[J]. BIOMETRICS, 1987, 43 (04) : 865 - 874
[9] ONE-SAMPLE MULTIPLE TESTING PROCEDURE FOR PHASE-II CLINICAL-TRIALS
FLEMING, TR
[J]. BIOMETRICS, 1982, 38 (01) : 143 - 151
[10] CALIBRATED PHASE-II CLINICAL-TRIALS IN ONCOLOGY
HERSON, J
CARTER, SK
[J]. STATISTICS IN MEDICINE, 1986, 5 (05) : 441 - 447